Aldeyra Therapeutics (ALDX) Posts Q1 Loss of $1.56/Share

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q2 EPS of ($1.56), $1.03 worse than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Restoration Hardware (RH) PT Raised to $130 at Stifel After Q1 Earnings
• The Lovesac Company (LOVE) Tops Q1 EPS by 29c